| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of MAFB mRNA | decreases expression | 19933214
|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of MAFB mRNA | affects expression | 21346803
|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of MAFB mRNA | affects expression | 21346803
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MAFB mRNA | affects expression | 16483693
|
| D001194 |
Asbestos |
Asbestos affects the expression of MAFB mRNA | affects expression | 17297452
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAFB mRNA | decreases expression | 20018196
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MAFB mRNA | increases expression | 20382639 19150397
|
| D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of MAFB mRNA | increases expression | 15171707
|
| D002117 |
Calcitriol |
Calcitriol results in increased expression of MAFB mRNA | increases expression | 16002434
|
| D005419 |
Flavonoids |
Flavonoids results in increased expression of MAFB mRNA | increases expression | 18035473
|
| C106014 |
gedunin |
gedunin results in decreased expression of MAFB mRNA | decreases expression | 17010675
|
| D019833 |
Genistein |
Genistein results in increased expression of MAFB mRNA | increases expression | 18847459
|
| C533894 |
LG 100815 |
LG 100815 results in decreased expression of MAFB mRNA | decreases expression | 16951191
|
| D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of MAFB mRNA | increases expression | 12057914
|
| C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in increased expression of MAFB mRNA | increases expression | 20024957
|
| C044361 |
M-VAC protocol |
MAFB protein results in increased susceptibility to M-VAC protocol | increases response to substance | 15814643
|
| C062198 |
octa-2,4,6-trienoic acid |
octa-2,4,6-trienoic acid results in decreased expression of MAFB mRNA | decreases expression | 16951191
|
| D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of MAFB mRNA] | affects reaction|decreases expression | 19482888
|
| D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of MAFB mRNA | decreases expression | 19482888 19270015
|
| D010634 |
Phenobarbital |
Phenobarbital results in increased expression of MAFB mRNA | increases expression | 19270015
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MAFB mRNA | affects binding|decreases expression|increases activity | 19710929
|
| C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of MAFB mRNA | decreases expression | 17426115
|
| C006253 |
pirinixic acid |
pirinixic acid results in increased expression of MAFB mRNA | increases expression | 18445702
|
| C009250 |
sevoflurane |
sevoflurane affects the expression of MAFB mRNA | affects expression | 15967596
|
| C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of MAFB mRNA | decreases expression | 16882884
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MAFB mRNA | decreases expression | 17517823
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MAFB mRNA | decreases expression | 19933214
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MAFB mRNA | increases expression | 17275934
|
| D013849 |
Thimerosal |
Thimerosal results in increased expression of MAFB mRNA | increases expression | 16870260
|
| C050414 |
tripterine |
tripterine results in decreased expression of MAFB mRNA | decreases expression | 17010675
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
7.79 | 6195326 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.79 | 15322242 11752688 14514962 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.41 | 18287403 |
| MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.57 | 18653653 11850527 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.57 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Genistein |
2.44 | 11473722 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
16.40 | 17620307 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
16.40 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
16.40 | 16835633 |
| MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.33 | 15469931 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.81 | 11748828 |
| MESH:D050197 |
Atherosclerosis |
|
Asbestos |
4.13 | 18795166 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.31 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.31 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.64 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.67 | 15746008 |
| MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
1.96 | 11237771 |
| MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
1.96 | 15324884 17129689 |
| MESH:D001943 |
Breast Neoplasms |
|
Genistein |
1.96 | 16541309 16873071 17200150 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.68 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.62 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.62 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
8.62 | 16924424 15948411 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
8.62 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
8.62 | 17173139 20007298 1701930 6705139 20935162 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.58 | 11237771 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.28 | 16120746 18670907 18850075 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.20 | 16332659 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
10.72 | 6135515 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.72 | 20889678 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
10.72 | 19716837 |
| MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.10 | 4080065 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.03 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.71 | 19176532 |
| MESH:D002971 |
Cleft Lip |
marker/mechanism |
|
| 20436469 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.04 | 8697196 16354765 15340226 12621046 15668235 |
| MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.26 | 17182828 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
2.73 | 10525206 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.73 | 10048152 20055451 15322242 |
| MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.41 | 16002989 12952375 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.39 | 18551238 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.39 | 18551238 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
|
Thimerosal |
4.39 | 16958921 15932584 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.36 | 18249437 |
| MESH:D002658 |
Developmental Disabilities |
|
Thimerosal |
4.74 | 15764492 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.20 | 16647724 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.20 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.63 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.63 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
8.63 | 18186108 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.63 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.65 | 11462148 |
| MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.86 | 1851702 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
6.08 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.08 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.75 | 18230668 15322242 16714409 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
3.79 | 15138306 |
| MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
11.38 | 16402032 |
| MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
11.38 | 16402032 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
7.36 | 15700306 16804899 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.36 | 11473722 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.89 | 9294722 10568697 |
| MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.24 | 15328337 17637181 15821434 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.96 | 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.72 | 3922381 11558140 |
| MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.81 | 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.41 | 6401628 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.10 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.87 | 3659116 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.04 | 20426865 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
2.63 | 20131406 19236843 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.56 | 16002989 16513791 16534752 16611131 15751030 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.31 | 11858732 |
| MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.88 | 9205823 11852909 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.80 | 20067830 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.79 | 16452187 |
| MESH:D005909 |
Glioblastoma |
|
Genistein |
3.16 | 16598420 |
| MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
4.94 | 19446573 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.44 | 10696789 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.25 | 10048152 11294989 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.44 | 20558911 |
| MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.25 | 16366002 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.20 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
13.51 | 16109766 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.51 | 18467677 16221962 19176532 19772884 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.51 | 15340226 12621046 16120746 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.89 | 16959395 15340226 18606429 8697196 16354765 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.05 | 20558911 |
| MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.29 | 14722030 12960047 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.85 | 18670907 18850075 |
| MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.43 | 16002989 |
| MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.21 | 15036965 |
| MESH:D007249 |
Inflammation |
|
Flavonoids |
7.92 | 17296493 |
| MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
7.92 | 17255318 17237260 17963957 12878042 9205823 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.92 | 12878042 12200463 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.53 | 16306350 |
| MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.49 | 17255318 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.20 | 16580747 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
11.74 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
11.74 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
11.74 | 14681315 15003126 16762066 |
| MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
9.49 | 17184923 |
| MESH:D007859 |
Learning Disorders |
|
sevoflurane |
9.49 | 19212262 |
| MESH:D007938 |
Leukemia |
|
Genistein |
2.95 | 17468513 18980019 |
| MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.55 | 15821434 |
| MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
2.81 | 21047994 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
4.81 | 17823541 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
4.81 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.81 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.81 | 12878042 |
| MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.14 | 19363144 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
13.62 | 7678174 |
| MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
13.62 | 16712894 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
13.62 | 8742319 19812893 15975961 19482888 21047994 19073162 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
13.62 | 20007298 16377806 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.62 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.25 | 2876784 2876786 6135515 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
9.25 | 17172636 2563599 1399818 6150874 18308698 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.25 | 12151625 |
| MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.86 | 21114838 |
| MESH:D008175 |
Lung Neoplasms |
|
Asbestos |
2.73 | 12111688 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.73 | 11884234 19555203 |
| MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
5.00 | 15166399 |
| MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
3.37 | 15700306 |
| MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.36 | 16002989 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
2.85 | 12929590 14578162 |
| MESH:D008569 |
Memory Disorders |
|
sevoflurane |
4.60 | 19212262 |
| MESH:D008654 |
Mesothelioma |
|
Asbestos |
4.03 | 16919927 16319530 18310086 16564556 18709470 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.36 | 16239165 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.72 | 18186108 |
| MESH:D009203 |
Myocardial Infarction |
|
Genistein |
5.47 | 17141266 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.47 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.90 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.00 | 17141266 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.00 | 16411023 |
| MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.32 | 17484760 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.84 | 18551238 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.84 | 18551238 7678174 |
| MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
4.79 | 15313581 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.79 | 17405874 |
| MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
15.58 | 11399458 |
| MESH:D009421 |
Nervous System Malformations |
|
Genistein |
15.58 | 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.58 | 14600291 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
3.86 | 10525206 11749123 18186108 19446573 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.78 | 20558911 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.44 | 12819281 16049721 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.44 | 16049721 |
| MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.21 | 17016548 |
| MESH:D010024 |
Osteoporosis |
|
Genistein |
3.16 | 19401787 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.94 | 16169203 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
2.55 | 19005980 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.44 | 16965848 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.10 | 12520081 |
| MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
5.02 | 14722030 |
| MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.52 | 15687265 16977796 |
| MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.40 | 12224865 11605937 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.41 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.49 | 2563599 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
9.06 | 17184923 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.06 | 11896295 11118676 11399792 11222880 |
| MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.63 | 15572423 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.73 | 16289102 15754350 18247401 12479363 16644109 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
2.73 | 17136230 15046698 15846301 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.73 | 16925846 15256057 15378649 |
| MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.34 | 12752131 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.31 | 19058328 |
| MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.63 | 10835634 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.69 | 18990726 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
9.21 | 18551238 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.21 | 18551238 |
| MESH:D012640 |
Seizures |
|
Phenobarbital |
9.21 | 3137016 16876388 4039156 11442880 |
| MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.67 | 6407741 |
| MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
3.34 | 17431481 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
4.56 | 16709447 16002989 |
| MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.03 | 15821434 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.75 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
2.94 | 1399818 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
11.50 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
11.50 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
11.50 | 16712894 17306315 16452187 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
11.50 | 20375083 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
20.19 | 10091137 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
20.19 | 10091137 |
| MESH:D014571 |
Urologic Neoplasms |
|
M-VAC protocol |
20.19 | 17933135 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
3.90 | 16175088 |
| MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
5.02 | 14652134 |
| MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
3.92 | 16690809 15809267 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
4.29 | 16513791 16002989 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.44 | 12125929 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.10 | 15886252 |